These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24286566)

  • 1. Dichotomous location of 160 atypical femoral fractures.
    Koeppen VA; Schilcher J; Aspenberg P
    Acta Orthop; 2013 Dec; 84(6):561-4. PubMed ID: 24286566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenesis of atypical femoral fracture].
    Iwata K; Mashiba T
    Clin Calcium; 2016 Jan; 26(1):73-9. PubMed ID: 26728533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
    Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
    Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries.
    Wang Z; Ward MM; Chan L; Bhattacharyya T
    Osteoporos Int; 2014 Aug; 25(8):2109-16. PubMed ID: 24846316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.
    Thompson RN; Phillips JR; McCauley SH; Elliott JR; Moran CG
    J Bone Joint Surg Br; 2012 Mar; 94(3):385-90. PubMed ID: 22371548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate use and atypical fractures of the femoral shaft.
    Schilcher J; Michaëlsson K; Aspenberg P
    N Engl J Med; 2011 May; 364(18):1728-37. PubMed ID: 21542743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
    Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
    BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene.
    Vestergaard P; Schwartz F; Rejnmark L; Mosekilde L
    Osteoporos Int; 2011 Mar; 22(3):993-1001. PubMed ID: 21165600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
    Chang ST; Tenforde AS; Grimsrud CD; O'Ryan FS; Gonzalez JR; Baer DM; Chandra M; Lo JC
    Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates.
    Nieves JW; Cosman F
    Curr Osteoporos Rep; 2010 Mar; 8(1):34-9. PubMed ID: 20425089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
    Png MA; Mohan PC; Koh JSB; Howe CY; Howe TS
    Osteoporos Int; 2019 Dec; 30(12):2417-2428. PubMed ID: 31435684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users.
    Lee SH; Lee YH; Suh JS
    AJR Am J Roentgenol; 2017 Oct; 209(4):867-873. PubMed ID: 28796551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical fractures do not have a thicker cortex.
    Koeppen VA; Schilcher J; Aspenberg P
    Osteoporos Int; 2012 Dec; 23(12):2893-6. PubMed ID: 23076682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical bisphosphonate-associated subtrochanteric and femoral shaft stress fractures: diagnostic features on bone scan.
    Probst S; Rakheja R; Stern J
    Clin Nucl Med; 2013 May; 38(5):397-9. PubMed ID: 23478849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Femoral insufficiency fractures with bisphosphonate therapy. Cases study.
    Boszczyk A; Kowalski D; Zakrzewski P; Pomianowski S
    Ortop Traumatol Rehabil; 2011; 13(4):403-8. PubMed ID: 21857071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.
    Lenart BA; Neviaser AS; Lyman S; Chang CC; Edobor-Osula F; Steele B; van der Meulen MC; Lorich DG; Lane JM
    Osteoporos Int; 2009 Aug; 20(8):1353-62. PubMed ID: 19066707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features.
    Giusti A; Hamdy NA; Dekkers OM; Ramautar SR; Dijkstra S; Papapoulos SE
    Bone; 2011 May; 48(5):966-71. PubMed ID: 21195812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: sensitivity and trim and fill studies.
    Liu J; Zhang HX; Lu XX; Hu JJ; Deng LF
    Genet Test Mol Biomarkers; 2014 Feb; 18(2):117-22. PubMed ID: 24205872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical femoral fractures in association with bisphosphonate therapy: a case series.
    Rheinboldt M; Harper D; Stone M
    Emerg Radiol; 2014 Oct; 21(5):557-62. PubMed ID: 24687462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The advantages of tomosynthesis for evaluating bisphosphonate-related atypical femur fractures compared to radiography.
    Petraszko A; Siegal D; Flynn M; Rao SD; Peterson E; van Holsbeeck M
    Skeletal Radiol; 2016 May; 45(5):615-23. PubMed ID: 26861160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.